Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Satellos Bioscience Inc (MSCLF)

Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Satellos Bioscience Inc 200 BAY STREET SUITE 2800 TORONTO A6 M5J 2J1 CAN

https://satellos.com P: 64-7660-1780

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Satellos Bioscience Inc. is a regenerative medicine company dedicated to developing novel therapeutics which stimulate or restore muscle regeneration in severe disorders. The company's lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy. Satellos Bioscience Inc., formerly known as iCo Therapeutics Inc., is based in Toronto, Ontario.

Key Statistics

Overview:

Market Capitalization, $K 88,413
Enterprise Value, $K 46,333
Shares Outstanding, K 185,507
Annual Sales, $ 0 K
Annual Net Income, $ -20,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,820 K
EBIT, $ -20,890 K
EBITDA, $ -17,380 K
60-Month Beta 1.16
% of Insider Shareholders 37.90%
% of Institutional Shareholders 0.00%
Float, K 115,200
% Float 62.10%
Short Volume Ratio 0.89

Growth:

1-Year Return -20.66%
3-Year Return -28.86%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 11/14/25
Next Earnings Date 11/12/25
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MSCLF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -39.05%
Return-on-Assets % -36.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.23
Book Value/Share 0.22
Interest Coverage -2.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar